Shortening the diagnostic odyssey—the impact of whole genome sequencing in the NHS Post date 4 November 2021 ← Use of whole genome sequencing to determine genetic basis of suspected mitochondrial disorders → Under-reporting of deaths limits our understanding of true burden of covid-19